Wednesday, July 28, 2021
News

ICMR partners with BBIL for developing indigenous COVID-19 vaccine

   SocialTwist Tell-a-Friend    Print this Page   COMMENT

New Delhi, May 9 | May 9, 2020 10:41:54 PM IST
The Indian Council of Medical Research (ICMR) on Saturday announced that it has partnered with the Bharat Biotech International Limited (BBIL) to develop a fully indigenous vaccine for COVID-19 using the virus strain isolated at the National Institute of Virology (NIV), Pune.

"The ICMR and BBIL have partnered to develop a fully indigenous vaccine for COVID-19 using the virus strain isolated at the ICMR''s NIV, Pune," a ICMR statement said.

The strain has been successfully transferred from NIV to BBIL and work on vaccine development has been initiated between the two partners.

While the ICMR-NIV will provide continuous support to BBIL for vaccine development, the ICMR and BBIL will seek fast-track approvals to expedite vaccine development, subsequent animal studies and clinical evaluation of the candidate vaccine. (ANI)

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Two Nigerians among six drug-peddlers ar...
'Mediation the best solution': SC on Kir...
Cong delegation meets Goa Guv, demands d...
Yediyurappa reaches legislature party me...
Kerala: Catholic diocese in Pala announc...
Himachal Governor expresses pain at natu...
More...    
 
 Top Stories
Russia confirms 23,032 new Covid ca... 
Rajasthan launches 'Niryatak Bano' ... 
Gurugram DC issues directions to re... 
Initiatives taken to popularise Ayu... 
Own up ward, village secretariats, ... 
MoES launches new Earth System Scie... 
AP's Disha app helps parents find '... 
Groupe ADP, GMR execute industrial ...